DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Seymour S.
Briefing Information for the March 9, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee. NDA 22-535.
Washington, D.C.:
US Food and Drug Administration; 2010 Available from:
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM203081.pdf [accessed 2010 May 10]
We do not assume any responsibility for the contents of the web pages of other providers.